1. A Kindred with a β-Globin Base Substitution [β89(F5)Ser→Arg (AGT>AGG); HBB: c.270T>G] Resulting in Hemoglobin Vanderbilt. (3rd September 2019) Authors: Shomali, William; Brar, Rondeep; Arekapudi, Subramanyeswara R.; Gotlib, Jason R. Journal: Hemoglobin Issue: Volume 43:Number 4/5(2019) Page Start: 273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto‐oncogene, receptor tyrosine kinase (KIT) D816V mutations. (1st June 2021) Authors: Naumann, Nicole; Lübke, Johannes; Shomali, William; Reiter, Lukas; Horny, Hans‐Peter; Jawhar, Mohamad; Dangelo, Vito; Fabarius, Alice; Metzgeroth, Georgia; Kreil, Sebastian; Sotlar, Karl; Oni, Claire; Harrison, Claire; Hofmann, Wolf‐Karsten; Cross, Nicholas C. P.; Valent, Peter; Radia, Deepti; Go... Journal: British journal of haematology Issue: Volume 194:Number 2(2021) Page Start: 344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Late presentation of dyskeratosis congenita. (5th August 2019) Authors: Shomali, William; Brar, Rondeep Journal: British journal of haematology Issue: Volume 187:Number 3(2019) Page Start: 273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safe and effective use of ponatinib in a patient with chronic myeloid leukemia and acute venous thromboembolism on therapeutic anti-coagulation. Issue 1 (2nd January 2016) Authors: Shomali, William; Redmond, Cheryl; Bogati, Samjhana; Zimmerman, Cassandra; Visconte, Valeria; Tabarroki, Ali; Kalaycio, Matt; Tiu, Ramon V. Journal: Leukemia & lymphoma Issue: Volume 57:Issue 1(2016:Jan.) Page Start: 193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience. Issue 11 (18th September 2020) Authors: Azizi, Armon; Ediriwickrema, Asiri; Dutta, Ritika; Patel, Shyam A.; Shomali, William; Medeiros, Bruno; Iberri, David; Gotlib, Jason; Mannis, Gabriel; Greenberg, Peter; Majeti, Ravindra; Zhang, Tian Journal: Leukemia & lymphoma Issue: Volume 61:Issue 11(2020) Page Start: 2700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience. Issue 11 (18th September 2020) Authors: Azizi, Armon; Ediriwickrema, Asiri; Dutta, Ritika; Patel, Shyam A.; Shomali, William; Medeiros, Bruno; Iberri, David; Gotlib, Jason; Mannis, Gabriel; Greenberg, Peter; Majeti, Ravindra; Zhang, Tian Journal: Leukemia & lymphoma Issue: Volume 61:Issue 11(2020) Page Start: 2700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. World Health Organization‐defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management. Issue 10 (10th September 2019) Authors: Shomali, William; Gotlib, Jason Journal: American journal of hematology Issue: Volume 94:Issue 10(2019:Oct.) Page Start: 1149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. World Health Organization‐defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Issue 1 (8th October 2021) Authors: Shomali, William; Gotlib, Jason Journal: American journal of hematology Issue: Volume 97:Issue 1(2022) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗